Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays
Federici, A.B.; Canciani, M.T.; Forza, I.; Cozzi, G.
Thrombosis and Haemostasis 84(6): 1127-1128
2000
ISSN/ISBN: 0340-6245 PMID: 11154131 Document Number: 515820
Document emailed within 1 workday
Related Documents
Chang, P.; Aronson, D.L. 1997: Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities Thrombosis and Haemostasis 78(2): 930-933Dowling, S.V.; Ekert, H. 1976: A comparison of two methods for measurement of von Willebrand's factor (ristocetin cofactor) Thrombosis and Haemostasis 36(1): 284-285
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Veyradier, A.; Fressinaud, E.; Boyer-Neumann, C.; Trossaert, M.; Meyer, D. 2000: Von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system Thrombosis and Haemostasis 84(4): 727-728
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. III. Binding of plasma factor VIIi to platelets in the presence of ristocetin Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(4): 910-920
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Woods, A.I.; Sutton, N.M.; Kempfer, A.C.; Casillas, G.; Lazzari, M.A. 1985: Use of ultrasonicated plasma as a diluent in the technic for measuring ristocetin cofactor Sangre 30(6): 999-1006
Wright, R.D.; Krauss, J.S. 1990: A comparison of two macroscopic platelet agglutination assays for von Willebrand factor Annals of Clinical and Laboratory Science 20(1): 73-78
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Neugebauer, B.M.; Goy, C.; Seitz, R. 2002: A collagen binding assay: an additional method for von Willebrand factor activity in therapeutic concentrates Thrombosis and Haemostasis 88(5): 871-872
Al-Awadhi, A.M.; Olusi, S.O.; al-Zaid, N.S.; Prabha, K.; al-Jarallah, K.H.; Ahmed, A.H.; al-Salem, I.; Sedeqi, H.; Atteyah, Y. 1998: Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 569-572
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Patel, V.B.; Singh, R.; Connolly, C.; Kasprowicz, V.; Zumla, A.; Ndungu, T.; Dheda, K. 2010: Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting Plos one 5(12): E15664
Chou, C.-H.; Hsu, H.-L.; Lee, L.-N.; Hsueh, P.-R.; Luh, K.-T. 2009: Comparison of 2 interferon-gamma assays and Roche Cobas Amplicor Mycobacterium tuberculosis assay for rapid diagnosis of tuberculosis among patients with suspected tuberculosis in Taiwan Journal of Microbiology Immunology and Infection 42(3): 251-257
Cremer, M.A.; Hernandez, A.D.; Townes, A.S.; Stuart, J.M.; Kang, A.H. 1983: Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type Ii collagen Journal of Immunology 131(6): 2995-3000
Gao, L.-J.; Chen, J.-L.; Chen, J.; Gao, R.-L.; Yang, Y.-J.; Xu, B.; Qin, X.-W.; Qiao, S.-B.; Yao, M.; Liu, H.-B.; Wu, Y.-J.; Yuan, J.-Q.; Chen, J. 2008: Comparison of different drug-eluting stents in the treatment of coronary artery disease: a single center four-year clinical follow-up Zhonghua Nei Ke Za Zhi 47(7): 541-544
Olson, J.D.; Zaleski, A.; Herrmann, D.; Flood, P.A. 1989: Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin Journal of Laboratory and Clinical Medicine 114(1): 6-18
Goudemand, J.; Mazurier, C.; Parquet-Gernez, A.; Goudemand, M. 1977: HLA antigen and Willebrand's disease Pathologie-Biologie 25(4): 241-243
Laferté, S.; Dennis, J.W. 1988: Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells Cancer Research 48(17): 4743-4748